Wendy Stock to Thrombocythemia, Essential
This is a "connection" page, showing publications Wendy Stock has written about Thrombocythemia, Essential.
Connection Strength
0.031
-
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Am J Hematol. 1996 May; 52(1):42-6.
Score: 0.031